Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ALMR

Alamar Biosciences (ALMR) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $25.27 -2.5% on the day +14.9% over 12 months 52-week range $19.09 – $38.13

Share price and insider trades

ALMR closeInsider buyInsider sale
10203040MayJunJulAugSepOctEEarnings release filed 2026-05-08EEarnings release filed 2026-08-10Bought $7,999,996 on 2026-04-20 · Illumina Innovation Fund Ii Gp, L.L.C., Nicholas Naclerio
Bought, 12 months$8.0M
Sold, 12 months$0
Insiders buying2
Insiders selling0

Alamar Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $8.0M and 0 sold $0 of ALMR stock on the open market.

ALMR insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $8.0M bought (2 trades)$8.0MQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$8.0M2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day2.7×Last 5 sessions
Insiders' paper profit+$3.9MOn all tracked purchases +48.6%

Summary

Over the past 12 months, 2 Alamar Biosciences, Inc. insiders reported open-market purchases totaling $8.0M, while 0 insiders reported sales totaling $0.

ALMR earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 10, 2026 +9.9% None +28.5%S&P -0.3% -24.1%
May 8, 2026 -2.5% Bought $8.0M (2) +0.9%S&P +1.1% -9.9%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Apr 20SEC Nicholas NaclerioDirector Buy 235,294507,076 held (+87%) $17.00 $4.0M +48.6% —
Apr 20SEC Illumina Innovation Fund Ii Gp, L.L.C.10% Owner Buy 235,294507,076 held (+87%) $17.00 $4.0M +48.6% —

Insiders at Alamar Biosciences, Inc.

InsiderBoughtSoldLast filingScore
Nicholas NaclerioDirector $4.0M — Apr 20, 2026 —
Illumina Innovation Fund Ii Gp, L.L.C.10% Owner $4.0M — Apr 20, 2026 —

ALMR stock: common questions

Are Alamar Biosciences, Inc. insiders buying ALMR stock?

In the past 12 months, 2 insiders reported open-market purchases of ALMR worth $8.0M. The latest was Director Nicholas Naclerio bought $4.0M of ALMR at $17.00 — first open-market purchase in our records; raises the stake by 87%.

Are Alamar Biosciences, Inc. insiders selling ALMR stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ALMR's 52-week range?

Over the past year ALMR has traded between $19.09 and $38.13. It last closed at $25.27 on Oct 9, 2026.